Hostname: page-component-78c5997874-xbtfd Total loading time: 0 Render date: 2024-11-15T01:44:02.232Z Has data issue: false hasContentIssue false

Hepatitis virus and HIV infections in inmates of a state correctional facility in Mexico

Published online by Cambridge University Press:  08 March 2005

C. ALVARADO-ESQUIVEL
Affiliation:
Facultad de Medicina, Universidad Juárez del Estado de Durango, México
E. SABLON
Affiliation:
Innogenetics NV, Ghent, Belgium
S. MARTÍNEZ-GARCÍA
Affiliation:
Facultad de Medicina, Universidad Juárez del Estado de Durango, México
S. ESTRADA-MARTÍNEZ
Affiliation:
Instituto de Investigación Científica, Universidad Juárez del Estado de Durango, México
Rights & Permissions [Opens in a new window]

Abstract

Core share and HTML view are not available for this content. However, as you have access to this content, a full PDF is available via the ‘Save PDF’ action button.

We sought to determine the prevalence and associated characteristics of hepatitis A, B, C and D viruses and HIV infections in a prison in Durango, Mexico. Sera from 181 inmates were analysed for HAV antibody, hepatitis B core antibody (HBcAb), hepatitis B surface antigen (HBsAg), HCV antibody, HDV antibody, HIV antibody and HCV genotypes. Prevalence of HAV antibody, HBcAb, HBsAg, HCV antibody, HDV antibody and HIV antibody were 99·4, 4·4, 0·0, 10·0, 0·0 and 0·6% respectively. HCV genotype 1a predominated in HCV-infected inmates (62·5%), followed by HCV genotype 1b (25%) and HCV genotype 3 (12·5%). An association between HBV infection and age >30 years was found. HCV infection was associated with being born in Durango City, history of hepatitis, ear piercing, tattooing, drug abuse history, intravenous drug use and lack of condom use. We concluded that the prevalence of HAV, HBV, HDV and HIV infections in inmates in Durango, Mexico were comparable to those of the Mexican general population and blood donors, but lower than those reported in other prisons around the world. However, HCV infection in inmates was higher than that reported in Mexican blood donors but lower than those reported in other prisons of the world. These results have implications for the optimal planning of preventive and therapeutic measures.

Type
Research Article
Copyright
2005 Cambridge University Press